Showing results (1511-1520 of 1,571) with videos related to
Sort By:
Pageof 158
Malaria Journal|March 25, 2022
Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial GuineaMaxmillian Mpina, Thomas C Stabler, Tobias Schindler, et al.The Journal of Clinical Investigation|January 9, 2024
Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adultsSaid Jongo, L W Preston Church, Florence Milando, et al.Science (New York, N.Y.)|September 10, 2011
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunityJ E Epstein, K Tewari, K E Lyke, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2019
Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian AdultsSaid A Jongo, L W Preston Church, Ali T Mtoro, et al.The American Journal of Tropical Medicine and Hygiene|November 17, 2017
Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean MenAlly Olotu, Vicente Urbano, Ali Hamad, et al.Journal of Medicinal Chemistry|May 14, 2014
Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutationsTed W Johnson, Paul F Richardson, Simon Bailey, et al.Frontiers in Microbiology|January 8, 2015
Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injectionSusanne H Hodgson, Elizabeth Juma, Amina Salim, et al.The American Journal of Tropical Medicine and Hygiene|June 27, 2018
Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian AdultsSaid A Jongo, Seif A Shekalaghe, L W Preston Church, et al.The American Journal of Tropical Medicine and Hygiene|April 18, 2019
Safety and Differential Antibody and T-Cell Responses to the Plasmodium falciparum Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and InfantsSaid A Jongo, L W Preston Church, Ali T Mtoro, et al.Nature Communications|October 12, 2022
A consensus statement on detection of hippocampal sharp wave ripples and differentiation from other fast oscillationsAnli A Liu, Simon Henin, Saman Abbaspoor, et al.Pageof 158